Enlaza Therapeutics
Covalent Protein Biologics | Home
United States · Founded 2021 · $161.0M raised
- Founded
- 2021
- Business Model
- B2B
- Website
- enlazatx.com
- Total Funding
- $161.0M
- Last Round
- $100.0M Series AApr 2024
- Rounds
- 2
About
Enlaza Therapeutics is a preclinical-stage biotech developing first-in-class covalent protein therapeutics, or 'War-Lock' biologics, to treat cancer and other serious diseases. Its proprietary platform incorporates unnatural amino acids into protein drugs to create irreversible, target-specific covalent bonds, aiming to improve efficacy and reduce off-target toxicity compared to standard biologics. The company is backed by investors including J.P. Morgan Life Sciences Private Capital, Frazier Life Sciences, Avalon Ventures, Lightspeed Venture Partners, and Samsara BioCapital, and announced a strategic collaboration with Vertex Pharmaceuticals in September 2025.
Summary
Enlaza Therapeutics is a Biotech company based in United States, founded in 2021. It has raised $161.0M in total across 2 rounds, most recently a $100.0M Series A round in Apr 2024. Investors include J.P. Morgan Asset Management, Avalon Ventures and Amgen.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/enlaza-therapeutics"><img src="https://indexed.vc/api/badge/company/enlaza-therapeutics" alt="Enlaza Therapeutics on Indexed.vc" width="260" height="76" /></a>


